NASDAQ: AVIRAtea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?
Insider buying vs selling
Have Atea Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeanpierre Sommadossi | President CEO and Chairman | 2026-02-03 | 300,000 | $1.24 | $372.00kBuy |
| Wayne Foster | EVP Chief Accounting Officer | 2026-01-31 | 12,132 | $4.24 | $51.44kSell |
| Janet Mj Hammond | Chief Development Officer | 2026-01-31 | 14,136 | $4.24 | $59.94kSell |
| Andrea Corcoran | Chief Financial Officer Executive Vice President Legal and Secretary | 2026-01-31 | 16,104 | $4.24 | $68.28kSell |
| Jeanpierre Sommadossi | President CEO and Chairman | 2026-01-31 | 106,093 | $4.24 | $449.83kSell |
| John Vavricka | Chief Commercial Officer | 2026-01-31 | 11,570 | $4.24 | $49.06kSell |
| Maria Arantxa Horga | Chief Medical Officer | 2026-01-31 | 16,073 | $4.24 | $68.15kSell |
AVIR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVIR insiders and whales buy or sell their stock.
AVIR Shareholders
What type of owners hold Atea Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.87% | 8,491,202 | $36.60M | Institution |
| Bml Capital Management LLC | 9.59% | 7,490,000 | $32.28M | Institution |
| Jeanpierre Sommadossi | 8.49% | 6,633,855 | $28.59M | Insider |
| Cormorant Asset Management LP | 8.21% | 6,411,355 | $27.63M | Insider |
| Andrew A. F. Hack | 7.19% | 5,615,659 | $24.20M | Insider |
| Vanguard Group Inc | 5.41% | 4,227,110 | $18.22M | Institution |
| Geode Capital Management LLC | 2.36% | 1,841,001 | $7.93M | Institution |
| State Street Corp | 2.28% | 1,784,467 | $7.69M | Institution |
| Dimensional Fund Advisors LP | 1.76% | 1,373,946 | $5.92M | Institution |
| Jpmorgan Chase Co | 1.73% | 1,348,294 | $5.81M | Institution |
AVIR vs Biotech Stocks
Atea Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.